Minorities With MS Voice Interest in Clinical Trials, But Express Concerns

Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses how minorities with MS voice interest in clinical trials, but express concerns.

Multiple Sclerosis News Today’s columnist, Jessie Ace talks through her recent MS exacerbation in which she found mental strength and clarity.

=====================================

Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.

https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud

=====================================

Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/

=====================================

To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/